Vohra Rupali

Mouhammad Zaynab A, Tribble James R, Nicol Alan, Andreopoulou Evgenia, García-Bermúdez Mariana Y, Aldana Blanca I et al.

Semaglutide protected retinal ganglion cells from degeneration in a glaucoma model by enhancing retinal glucose metabolism, suggesting a potential neuroprotective strategy for glaucoma via metabolic flexibility.

Tribble James R, Kokkali Eirini, Otmani Amin, Plastino Flavia, Lardner Emma, Vohra Rupali et al.

Unilateral glaucoma models showed significant microglial activation in the contralateral "control" eye and visual pathways. This suggests caution when using the contralateral eye as a control in glaucoma research.

Vohra Rupali, Dalgaard Line Marie, Vibaek Jeppe, Langbøl Mia Aggergaard, Bergersen Linda Hildegaard, Olsen Niels Vidiendal et al.

This study found NTG patients had lower baseline serum lactate and amino acids, with altered hypoxic responses. This suggests systemic metabolic differences linked to NTG, potentially aiding diagnosis and understanding.

Vohra Rupali, Tsai James C, Kolko Miriam

This review explored inflammation's role in glaucoma, suggesting low-grade inflammation is a potential causal factor for progressive retinal ganglion cell death, offering new therapeutic avenues beyond IOP.